26.98000 USD
0.37
1.39%
Last update Dec 17, 3:59 PM EST
Market closed
Day range
26.5
27.69000
Previous close
26.61000
Open
26.70000
Access this stock data via API
Subscribe
Immunovant Inc.
26.98
0.37
1.39%

Financials

Income statement

Fiscal date 2025 2024 2023 2022
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 360.9M 212.9M 160.3M 101.8M
Selling general and admin 77.2M 57.3M 48.0M 54.2M
Other operating expenses
Operating income -438.2M -270.2M -208.3M -156.0M
Non operating interest income
Income 24.7M 24.9M 7.6M 0
Expense
Other income expense 471K -13.5M -10.3M -781K
Pretax income -412.9M -258.8M -211.0M -156.8M
Tax provision 891K 567K 9K -84K
Net income -413.8M -259.3M -211.0M -156.7M
Basic EPS -2.7 -1.9 -1.7 -1.4
Diluted EPS -2.7 -1.9 -1.7 -1.4
Basic average shares 151.6M 138.1M 123.1M 109.7M
Diluted average shares 151.6M 138.1M 123.1M 109.7M
EBITDA -437.8M -257.5M -198.1M -155.9M
Net income from continuing op. -413.8M -259.3M -211.0M -156.7M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 3 hours 54 minutes

00:05
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).